FDA Approves Pembrolizumab With Enfortumab Vedotin-ejfv For Muscle Invasive Bladder Cancer

Merck & Co., Inc. +1.30%

Merck & Co., Inc.

MRK

100.30

+1.30%

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-enfortumab-vedotin-ejfv-muscle-invasive-bladder-cancer

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via